The 2nd International Symposium on Human Microbiome Treatment to Overcome Human Diseases at Seoul National University Bundang Hospital
Sep 15, 2025
Bundang Seoul National University Hospital announced on the 12th that the '2nd International Symposium on Human Microbiome Treatment to Overcome Human Diseases' was held with great success.
The human microbiome refers to the genetic information of all microorganisms living in the human body. As the association with systemic diseases such as cerebrovascular disease, cardiovascular disease, and immune disease has recently been revealed, the development of diagnostic and therapeutic agents using the human microbiome is attracting attention as a next-generation treatment paradigm to overcome various intractable diseases.
Starting in 2023, the microbiome project group at Seoul National University Bundang Hospital is conducting research on diagnosing severe cerebrovascular diseases using the human microbiome and discovering new treatments (Research Director: Professor Kim Jun-yeop of Department of Neurology at Seoul National University Bundang Hospital). This international symposium was held with experts leading microbiome research at home and abroad to share the latest research results of the task and discuss future development directions.
Starting with Professor Oh Chang-wan of Chung-Ang University Gwangmyeong Hospital, the event was presented under the theme of ▲ Controlling atherosclerosis through the microbiome (Professor Park Young-mi of Ewha Womans University) ▲ Protecting bioactive substances derived from intestines in ischemic stroke (Dr. Jeong Hye-ri of Hanlim University) ▲ Microbiome characteristics of acute ischemic stroke patients (Professor Kim Jun-yeop of Bundang Seoul National University) ▲ The relationship between intestinal microbial metabolites and brain diseases (Professor Park Hyun-bong of Gangneung-Wonju National University).
In particular, Professor Jason Crawford of Yale University, who was invited as an overseas performer, received great response by presenting global research trends and future research tasks through a lecture on the theme of 「Metabolism at the Human-Microbe Interface」.
Professor Kim Jun-yup said, "While the microbiome is in the spotlight as a new treatment strategy for overcoming human diseases, it is meaningful to provide an in-depth search for research trends and future prospects in various diseases including cardio-cerebrovascular disease." We hope this discussion will serve as an opportunity for human microbiome research to take a leap forward."
The human microbiome refers to the genetic information of all microorganisms living in the human body. As the association with systemic diseases such as cerebrovascular disease, cardiovascular disease, and immune disease has recently been revealed, the development of diagnostic and therapeutic agents using the human microbiome is attracting attention as a next-generation treatment paradigm to overcome various intractable diseases.
Starting in 2023, the microbiome project group at Seoul National University Bundang Hospital is conducting research on diagnosing severe cerebrovascular diseases using the human microbiome and discovering new treatments (Research Director: Professor Kim Jun-yeop of Department of Neurology at Seoul National University Bundang Hospital). This international symposium was held with experts leading microbiome research at home and abroad to share the latest research results of the task and discuss future development directions.
Starting with Professor Oh Chang-wan of Chung-Ang University Gwangmyeong Hospital, the event was presented under the theme of ▲ Controlling atherosclerosis through the microbiome (Professor Park Young-mi of Ewha Womans University) ▲ Protecting bioactive substances derived from intestines in ischemic stroke (Dr. Jeong Hye-ri of Hanlim University) ▲ Microbiome characteristics of acute ischemic stroke patients (Professor Kim Jun-yeop of Bundang Seoul National University) ▲ The relationship between intestinal microbial metabolites and brain diseases (Professor Park Hyun-bong of Gangneung-Wonju National University).
In particular, Professor Jason Crawford of Yale University, who was invited as an overseas performer, received great response by presenting global research trends and future research tasks through a lecture on the theme of 「Metabolism at the Human-Microbe Interface」.
Professor Kim Jun-yup said, "While the microbiome is in the spotlight as a new treatment strategy for overcoming human diseases, it is meaningful to provide an in-depth search for research trends and future prospects in various diseases including cardio-cerebrovascular disease." We hope this discussion will serve as an opportunity for human microbiome research to take a leap forward."
|
This article was translated by Naver AI translator.
